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Protein misfolding within the endoplasmic reticulum (ER stress) can be a cause or consequence 
of pulmonary disease.  Mutation of proteins restricted to the alveolar type II pneumocyte can 
lead to inherited forms of pulmonary fibrosis, but even sporadic cases of pulmonary fibrosis 
appear to be strongly associated with activation of the unfolded protein response (UPR) and/or 
the integrated stress response (ISR).  Inhalation of smoke can impair protein folding and may be 
an important cause of pulmonary ER stress.  Similarly, tissue hypoxia can lead to impaired 
protein homeostasis (proteostasis).  But the mechanisms linking smoke and hypoxia to ER 
stress are only partially understood.  In this review, we will examine the role of ER stress in the 




The lung is a critical barrier between the external environment and the internal milieu.  
Transcriptional targets of CHOP allow the resumption of normal cellular processes during the 
dissipation of acute ER stress, supporting the resumption of protein synthesis and oxidative 
protein folding, via GADD34 and ERO1 upregulation respectively [1].  Failure to do so is 
implicated in a wider range of pulmonary diseases [2].  For many years, the cancer causing 
genotoxicity of inhaled pollutants has be studied in detail, but more recently it has become clear 
that additional effects on protein folding homeostasis (proteostasis) are also key to the 
development of lung disease [3, 4].  Failure of proteostasis specifically within the endoplasmic 
reticulum (so-called ER stress) has been shown to play an important role in the pathogenesis of 
many human diseases ranging from airway pathology to cancer [3-5].   
The response to ER stress called the Unfolded Protein Response (UPR) and the consequences 
of phosphorylating eIF2α (the Integrated Stress Response, ISR) have been described in depth 
elsewhere [3, 4, 6].  We shall therefore not discuss the individual pathways in great detail here 
apart from the following brief overview (Figure 1).  When proteins misfold inside the ER, a signal 
must be transmitted across the membrane to the cytosol and then the nucleus.  Three individual 
classes of ER stress sensor achieve this, but the outputs are essentially: (i) to lower the rate of 
protein synthesis and enhance the folding capacity of the ER while (ii) promoting disposal of 
terminally misfolded proteins and, finally (iii) to trigger cell death if homeostasis cannot be 
restored.  The reduction in translation is achieved by the combined actions of PERK and IRE1.  
PERK is a kinase that selectively phosphorylates eIF2α to lower the rate of translation initiation 
[7, 8].  By contrast, IRE1 is an endonuclease capable of degrading the mRNAs of some 
secretory proteins to prevent their synthesis in a process called Regulated IRE1 Dependent 
RNA Decay (RIDD) [9].  Following the initial reduction in protein synthesis, a complex 
transcriptional programme is induced by three parallel, yet interacting, pathways subordinate to 
three transcription factors -- one for each ER stress sensor (Figure 1).  PERK causes the 
preferential translation of ATF4 [10]; IRE1α initiates the unconventional splicing of XBP1 mRNA 
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into an active form [11-13]; and ATF6 is processed proteolytically into a soluble transcription 
factor at the Golgi apparatus [14, 15].  To enable the cell to adapt to its current load of ER client 
proteins these transcription factors induce genes encoding chaperones, enzymes required for 
new proteins to undergo post-translational modification, and components of the ER associated 
degradation (ERAD) machinery.  The mechanisms by which cell death is activated are less 
clear, but appear to occur following prolonged activation of ER stress signalling [1, 16].  
In this review, we shall examine the role of ER stress in the pathogenesis of lung disease by 
focusing on three main themes: the originals of pulmonary fibrosis, the effects of inhaled 
pollutants on the airway epithelium, and the wider consequences of impaired oxygenation that 
occurs during respiratory failure. 
Pulmonary fibrosis 
ER stress is associated with familial pulmonary fibrosis - Up to 30% of cases of pulmonary 
fibrosis have a genetic basis and, by studying these, ER stress has emerged as a potential 
pathogenic mechanism [17].  Type II pneumocytes of the alveolar epithelium secrete pulmonary 
surfactant to prevent surface tension from collapsing the airways.  This surfactant is composed 
of abundant lipids combined with a small number of proteins, one of which is surfactant protein 
C (SFTPC).  Autosomal dominant mutations of SFTPC can present as familial pulmonary 
fibrosis suggesting a toxic gain-of-function.  Paucity of cases of biallelic SFTPC mutation raises 
the possibility of a gene-dosage effect with only a single case being reported of a child born alive 
who was homozygous for an SFTPC mutation [18].  Deletion of exon 4 (∆exon4) of SFTPC was 
the first such mutation to be reported [19], but others including L188Q quickly followed [20].  
Both of these mutations and numerous others disrupt the C-terminal BRICHOS domain of the 
SFTPC pro-protein (Figure 2).  This domain is believed to function as a self-chaperone to 
facilitate the folding of SFTPC [21].  Consequently, these mutations hinder normal folding of 
SFTPC and impair its exit from the ER.  In heterologous expression models, SFTPC ∆exon4 
accumulates in the ER or in heavily ubiquitinated aggresomes and this is accompanied by 
activation of all three arms of the UPR [22-26].  Expression of SFTPC L188Q in mouse type II 
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pneumocytes also triggers the UPR in vivo but this is not sufficient to cause the development of 
pulmonary fibrosis [27].  However, SFTPC L188Q-expressing mice suffer exaggerated levels of 
fibrosis when challenged with other fibrogenic agents.  This may be a generalizable 
phenomenon, since the misfolding of other proteins within the ER of type II pneumocytes is also 
associated with the development of pulmonary fibrosis.  Surfactant protein A (SFTPA) is a 
hydrophilic surfactant protein with roles in innate immunity [28].  It too can be mutated in 
autosomal dominant pulmonary fibrosis and adenocarcinoma [29].  The pulmonary fibrosis-
associated mutations of SFTPA, G231V and F198S, trigger the splicing of XBP1 mRNA and 
induce the expression of BiP.  They do not, however, appear to exert a dominant negative effect 
on the trafficking of wild-type SFTPA suggesting, once again, that their toxicity is through a toxic 
gain-of-function mechanism. 
Pulmonary surfactant is assembled and stored by specialized structures within type II 
pneumocytes called lamellar bodies.  Its lipid component is transported into these organelles by 
the ABCA3 transporter [30] and so loss of ABCA3 function causes an autosomal recessive 
deficiency of surfactant [31, 32].  However, a subset of ABCA3 mutations is toxic owing to 
protein misfolding.  For example, the R280C and L101P mutants of ABCA3 are retained in the 
ER, induce expression of BiP, and sensitize cells to other ER stressing agents [33].  
Mistrafficking of surfactant components has similar effects.  Hermansky Pudlack syndrome 
(HPS) is a rare, recessive, form of oculocutaneous albinism caused by mutations in a variety of 
genes affecting lysosome maturation that in some patients can cause pulmonary fibrosis.  It can 
be caused by mutations of HPS1 and HPS4, which are components of the BLOC3 complex 
(biogenesis of lysosome-related organelles complex-3), a Rab32/38 guanine nucleotide 
exchange factor involved in the biogenesis of lysosome-related organelles [34].  The defective 
membrane trafficking resulting from these mutations leads to increased expression of CHOP 
and ATF4 in lung tissue, suggesting involvement of the UPR, or at least the ISR, in the 
pathogenesis of the disease [35]. 
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ER stress is associated with sporadic idiopathic pulmonary fibrosis (IPF) - Eighty-five 
percent of biopsy-proven cases of familial disease display histological changes consistent with 
so-called usual interstitial pneumonia (UIP) [36].  These changes are typical of the more 
common sporadic disorder idiopathic pulmonary fibrosis (IPF), and this similarity prompted a 
search for evidence of ER stress in sporadic IPF too.  Activation of the UPR has now been 
detected reproducibly in the lungs of individuals with sporadic IPF [25, 37, 38].  There is also 
evidence for UPR activation in the second most common form of sporadic idiopathic interstitial 
pneumonias (IIPs) called nonspecific interstitial pneumonia (NSIP) [39].  Not only can activation 
of the UPR be detected in explanted lungs from individuals with late stage pulmonary fibrosis, 
but also in relatively early diagnostic biopsies.  Although the association between sporadic IPF 
and activation of the UPR is strong, it remains correlative owing to the absence of a clear 
mechanistic link.  To address this, a number of lines of investigation are being pursued.  Chronic 
viral infection of the lung epithelium has been implicated in the pathogenesis of IPF (reviewed in 
[40]).  The DNA of herpes viruses (including CMV, EBV, HHV-7, HHV-8) can be detected in up 
to 97% of tissue samples from patients with IPF compared with 36% of controls [41].  This may 
be relevant because CMV infection has been shown to activate the UPR in cultured cells [42].  
Of course, the presence of viral DNA in tissue does not equate with infection, but herpes 
antigens, which are more indicative of chronic infection, were detected in 65% of individuals with 
UIP but were absent in all controls tested [25].  These viral antigens co-localized with markers of 
an activated UPR in the airway epithelium.  Nevertheless, the lack of viral antigens in many 
cases of IPF despite evidence of an active UPR suggests other ER stress-inducing agents may 
also be involved in the pathogenesis of pulmonary fibrosis.  For example, inhaled smoke is a 
plausible candidate (see later) since smoking cigarettes is a known risk factor for IPF and 
components of smoke can cause ER stress [43-51].  Equally, airborne particulate matter can 
activate the UPR in cultured cells and in the murine lung [52, 53], while exposure to airborne 
particulate matter is associated with more rapid progression of IPF [54].  It is likely that other, as 
yet unrecognised factors, may be involved including expression of other misfolding proteins or 
disorders of cellular proteostasis. 
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ER stress is associated with secondary pulmonary fibrosis – In a subset of patients, the 
development of pulmonary fibrosis can be attributed to a specific trigger.  And for some of these 
triggers, ER stress has emerged as a plausible mediator of toxicity.  For example, some 
individuals develop lung fibrosis due to the inhalation of asbestos fibres and are said to have 
asbestosis.  Their pulmonary histology closely resembles that of sporadic IPF and so a shared 
pathogenic mechanism seems plausible.  When explanted type II pneumocytes are exposed to 
asbestos fibres, activation of IRE1 can be detected [55].  The UPR is also detected in 
macrophages exposed to asbestos in vitro, and in the bronchial fluid of mice exposed to 
asbestos and humans suffering from asbestosis [56].  The antiarrhythmic drug amiodarone, 
which causes pulmonary toxicity in about 5% of patients and can also cause pulmonary fibrosis 
in mice, has also been shown to induce ATF6 and CHOP in cultured mouse lung epithelial cell 
lines [57, 58].  Another drug, bleomycin, is well known to cause pulmonary inflammation and 
fibrosis (so much so that it is commonly used to model interstitial lung disease in mice).  
Bleomycin can also activate the UPR following even a single intra-tracheal administration [59, 
60].  
Towards a mechanistic link between ER stress and pulmonary fibrosis – Current models 
suggest that pulmonary fibrosis develops when a susceptible pulmonary epithelium confronts an 
environmental trigger.  In such models, the factors rendering the epithelium vulnerable include 
age and genetics, while those acting as trigger might include viral infections and inhaled toxins.  
Studies suggest that cells already burdened with ER protein misfolding are less able to cope 
with the second proteotoxic insult.  For example, it has been shown that expression of proteins 
liable to misfold, such as the Z variant of α1-antitrypsin, can sensitize cells to drugs that impair 
protein folding, resulting in exaggeration of the UPR [61].  This may be relevant to the mice 
expressing L188Q SFTPC that do not spontaneously develop pulmonary fibrosis, but respond in 
an exaggerated manner to bleomycin with higher levels of apoptosis and fibrosis [27].  Similar 
synergy has been observed when wild type mice are treated with bleomycin in combination with 
the ER stress-inducing toxin, tunicamycin.  Likewise, the level of apoptosis and the degree of ER 
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stress caused by viral infection are both enhanced in cells already expressing the misfolding 
∆exon4 mutant of SFTPC [62].   
The incidence of IPF increases with age [63] and around 15% of cases of familial pulmonary 
fibrosis are related to mutations of the telomerase genes TERT and TERC that cause 
accelerated telomere shortening and premature senescence [64].  Interestingly, the ability of 
cells to withstand protein misfolding and ER stress also falls with age (reviewed in [65]) and 
older mice mount an exaggerated ER stress response following infection with herpes virus, 
which is associated with more pulmonary fibrosis [66].  The mechanism for this association 
might relate to a reduced capacity to turn over defective organelles, since ageing and ER stress 
both reduce the levels of PINK1 (PTEN-induced putative kinase 1) within lung epithelium [67].  
This results in impaired mitochondrial quality control with increased release of pro-fibrotic 
mediators such as TGFβ and FGF2 and elevated levels of apoptosis. 
ER stress may also induce inflammatory signaling through activation of NFκB and AP-1.  
Expression of ∆exon4 SFTPC induces the NFκB pathway [62, 68] and cells over-expressing 
misfolding mutants of SFTPC release IL8 owing to JNK/AP-1 activation [69].  IL8 is a potent 
chemo-attractant for neutrophils and is present at elevated levels in lung tissue, bronchoalveolar 
lavage fluid, sputum and serum from individuals with IPF patients compared with controls [70-
72].  But increased inflammation is not a major feature in the L188Q SFTPC expressing mouse 
[27].  Indeed, there was no excess of pulmonary inflammation in transgenic animals expressing 
low-levels of mutant protein compared to controls even following treatment with bleomycin, 
suggesting that ER stress may not promote fibrosis through effects on inflammation.  This 
chimes with theories in which IPF is not principally an inflammatory disorder, although 
microinjury and acute exacerbations of IPF do seem to correlate spatially and temporally with 
episodes of inflammatory cell activity (reviewed in [73]).  Instead, current research is focusing on 
epithelial injury followed by aberrant repair as the initiating events in IPF.  Prolonged exposure of 
primary alveolar epithelial cells to TGFβ induces an epithelial-to-mesenchyme transition (EMT) 
into collagen-producing myofibroblasts [74].  Such EMT has been observed in the lungs of 
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patients with IPF, in murine models of TGFβ-mediated lung injury, and in bleomycin-induced 
pulmonary fibrosis [75, 76].  Intriguingly, ER stress has been shown to trigger EMT in a variety of 
tissues including the lung [77, 78], while TGFβ appears to promote a more myofibroblast-like 
phenotype in pulmonary fibroblasts in an UPR-dependent manner [79].  Cultured lung epithelium 
forced to express either the L188Q or Δexon4 mutants of SFTPC or treated with the drug 
tunicamycin, which induces ER stress directly, underwent EMT in a src kinase-dependent 
manner [75, 76].  Moreover, inhibition of src or treatment with the chemical chaperone 4-phenyl 
butyric acid (4PBA) both ameliorated EMT suggesting a causal link between ER stress and this 
phenotypic change [60].  The precise mechanisms remain to be elucidated, but the IRE1-XBP1 
pathway has been implicated in driving EMT during pulmonary fibrosis through increased 
expression of the transcription factor Snail [80].  Other cell types in the lung may also be 
susceptible to ER stress-induced phenotypic changes.  For example, bleomycin-induced 
activation of the UPR in alveolar macrophages has been shown to induce a pro-fibrotic M2 
phenotype leading to increased secretion of TGFβ [81].  
Apoptotic death of epithelial cells is a recognized feature of pulmonary fibrosis (reviewed in [82]).  
Transgenic mice have been used to identify a cytotoxic effect of misfolding SFTPC mutants 
during lung development [23].  Exaggerated apoptosis also occurs in the lungs of mice 
expressing L188Q SFTPC when challenged with bleomycin and in cells expressing L188Q or 
∆exon4 SFTPC [20, 24, 25, 27].  This toxicity has been attributed to increased activation of 
caspase 4 and activation of JNK [26, 83].  Similarly, ER stress is thought to mediate cell death in 
models of pulmonary fibrosis associated mutation of ABCA3 [33].  Although correlative, it is 
interesting that markers of the unfolded protein response co-localize with apoptosis in fibrotic 
lungs from individuals with sporadic disease [37, 38].   
Smoke 
In addition to the potential link between smoke, ER stress and pulmonary fibrosis, proteomic 
analysis has identified elevated levels of ER chaperones in the lungs of patients with chronic 
obstructive pulmonary disease (COPD) [84].  This sparked interest in a potential role for smoke-
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induced ER stress as a mediator of COPD.  Despite apparent discrepancies in some of the 
effects of cigarette smoke in different disease models, smoke-induced ER stress appears to be 
initiated by perturbations in redox that lead, in many instances, to the triggering of cell death 
pathways [44-51, 85, 86].  
ER Stress is associated with exposure to smoke and pollutants in vitro – In vitro exposure 
of cells to cigarette smoke and other airborne pollutants can trigger the UPR [44-51].  When 
primary bronchial epithelial cells from non-smoking individuals were exposed for a brief period to 
whole cigarette smoke, transient PERK-dependent phosphorylation of eIF2α was observed 
followed by induction of ATF4 and GADD34 [44].  Similar results have been obtained for a 
variety of lung cancer and extra-pulmonary cell lines, with induction of UPR targets including 
BiP, XBP1 and GRP94 suggesting that smoke and aqueous smoke extracts are bona fide 
inducers of ER stress [44-48].  However, not all studies using primary airway epithelial cells 
have consistently reported ER stress to be caused by cigarette smoke [49, 50].  It has been 
suggested that the airway epithelium of patients with COPD may be more prone to smoke-
induced ER stress compared with non-smoking controls, which could account for some of these 
differences [49].  The mechanisms underlying this differential susceptibility is unclear, but the 
cells of patients with COPD are reported to show elevated basal levels of UPR markers, perhaps 
indicating that they have a pre-existing defect in ER homeostasis.  Moreover, volatile exhaust 
fumes from diesel engines, which can trigger the UPR in a dose-dependent manner [50], appear 
to activate the UPR in primary airway cells from COPD patients but not from non-smoking 
controls, supporting a notion that some individuals are innately more susceptible to airway ER 
stress [51]. Alternatively, this may indicate that the epithelium of COPD lungs is more 
susceptible to ER stress for other reasons, for example an abnormal microenvironment. 
Despite good evidence for activation of PERK and ATF6 by cigarette smoke in vitro, the 
involvement of the IRE1α-XBP1 axis is less straightforward.  Little or no splicing of XBP1 mRNA 
was observed when fibroblasts or lung-derived cancer cell lines were treated with aqueous 
smoke extract or volatile smoke respectively [44, 45].  Indeed, it has been suggested that 
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cigarette smoke can inhibit splicing of XBP1, ameliorating IRE1α-XBP1 signalling even when 
cells are treated with strong inducers of the ER stress such as tunicamycin [44, 53].  It is 
noteworthy that, in contrast to many other tissues, the lung and gut express two IRE1 
paralogues at appreciable levels [87].  Unlike the ubiquitously expressed IRE1α isoform, IRE1ß 
has been suggested to possess only low levels of XBP1-directed RNAse activity and so plays 
only a minor role in the IRE1-XBP1 pathway; instead, it seems to be more important in RIDD 
[88, 89].  Indeed, in lung cells treated with diesel fume particulates, despite a low level of XBP1 
splicing, increased levels of RIDD have been observed [53].  This refinement of the UPR in the 
lung and gut appears related to the secretion of mucin, because Ire1b-/- deficient mice aberrantly 
accumulate mucin within the ER of goblet cells owing to increased stability of MUC2 mRNA [90].  
IRE1ß may therefore function to regulate mucin production by degrading excess MUC2 mRNA.  
This raises the intriguing possibility that IRE1ß-directed therapies might plausibly be developed 
to regulate mucus production in smokers with COPD. 
ER Stress is following exposure to smoke and pollutants in vivo – The lung tissue of 
individuals with COPD has been shown to express elevated levels of UPR and ISR markers [84, 
91].  Similarly, the lungs of rats exposed to cigarette smoke for two to four months have 
increased levels of phosphorylated eIF2α and express the ISR target CHOP [92].  However, 
studies in mice have been less consistent.  When mice were exposed to the smoke of a single 
cigarette, activation of all three arms of the UPR could be detected within twelve hours [85], and 
mice chronically exposed to fine particulate matter induced both the ISR and UPR in their lungs 
[53].  However, in other studies, protein lysates of the lungs of mice exposed chronically to 
cigarette smoke failed to show evidence of a UPR [49, 93, 94].  This might indicate a species 
difference in the response to cigarette smoke, since transcriptional profiling also revealed few 
genes that are commonly modulated between smoke-exposed mice and humans with COPD 
[95].  Alternatively, it may represent a problem of detection sensitivity because 
immunohistochemistry has revealed localized increases in BiP and CHOP protein selectively in 
the bronchial epithelium of mice chronically exposed to smoke [93], while mRNA levels of BiP 
and CHOP were increased following prolonged smoke exposure when measured by northern 
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blot [47].  It is worth noting that the susceptibility of mice to developing emphysema or cancer 
following exposure to cigarette smoke is highly strain dependent [96-99], but it is as yet unclear 
if the UPR shows similar strain effects in mice. 
The role of redox in smoke-induced ER stress – At least some of the impairment of ER 
homeostasis caused by cigarette smoke is mediated through effects on cellular redox status.  
Cigarette smoke contains many potent oxidizing agents and so the lungs of humans and mice 
exposed to smoke have elevated levels of oxidized macromolecules [46, 100].  Similar 
biochemical changes are observed when human airway epithelial cells are treated with smoke 
condensate in vitro [101, 102].  Importantly, co-administration of an anti-oxidant, such as N-
acetylcysteine, along with smoke attenuates the induction of both the ISR and UPR, while 
reducing the level of cell death [45, 47, 48, 85, 86].   
An important function of the ER is the formation of disulphide bonds in many of its client proteins 
during oxidative protein folding [103].  This requires the ER to maintain a finely balanced redox 
environment that permits the formation of disulphide bonds, while also allowing aberrant 
disulphides to be reduced.  This may explain the sensitivity of the ER to the noxious effects of 
oxidants in smoke.  Protein disulphide isomerase (PDI) is a redox sensitive chaperone that 
undergoes cycles of oxidation and reduction through interactions with the enzyme ERO1 [103].  
This generates disulphide bonds within PDI that are passed on to its client proteins during 
oxidative protein folding.  Exposure to a variety of constituents of smoke, including acrolein, 
hydroxyquinones or peroxynitrites, leads to nitrosylation of PDI on cysteine and tyrosine 
residues impairing this enzymatic activity [46].  The resulting protein misfolding within the ER 
leads to ER stress.  Treatment of cells or mice with acrolein rapidly induces GADD34, which 
appears to mediate some of acrolein’s toxicity [104].  Just as GADD34 deficient mice are 
protected from the toxicity of ER stress [1], Gadd34-/- mice exposed chronically to intra-nasal 
acrolein are more resistant to cell death and have better preserved pulmonary architecture [104].  
Inhibition of GADD34 might therefore be expected to protect the lung from smoke-induced ER 
stress, but although putative GADD34 inhibitors have been reported, their effectiveness remains 
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somewhat controversial [105, 106].  Nevertheless, salubrinal, a drug that is said to inhibit the 
dephosphorylation of eIF2α, also protects cells from smoke [107].   
Chronic exposure to cigarette smoke leads to the induction of anti-oxidant pathways and 
detoxification enzymes both in humans and rodents [84, 108].  Although many of these genes 
are induced by the oxidative stress-response transcription factor Nrf2 [109, 110], the ISR also 
participates by inducing anti-oxidant genes via ATF4 [4, 111].  It has been suggested that Nrf2 
and ATF4 may even heterodimerize to regulate expression of some of their target genes [112, 
113] and, more recently, Nrf2 has been shown to regulate some genes through driving 
increased expression of ATF4 [114].  Interestingly, a signature suggesting regulation by ATF4 
was found amongst genes induced in the airway of smokers with COPD compared to smokers 
without COPD [115].  Subsequently, overexpression of ATF4 was shown to recapitulate this 
profile in cultured airway epithelial cells.  
Although early reports suggested that PERK is able to phosphorylate Nrf2 directly leading to its 
activation [116, 117], subsequent studies have demonstrated that the effects of PERK on target 
gene expression are entirely dependent on phosphorylation of eIF2a [118].  The relevance of 
Nrf2 to UPR signalling therefore remains uncertain.   
A role of ER stress in smoke-induced cell death – Cigarette smoke is highly noxious and 
smoke-induced cell death appears to play an important role in the pathogenesis of COPD [119].  
Several studies have suggested that ER stress may mediate some of this toxicity.  Although the 
mechanisms by which ER stress triggers apoptosis are complex and only partly understood 
(reviewed in [120]), the recovery of protein synthesis during late stages of the UPR is thought to 
contribute to ER stress-induced cell death [1].  This recovery of protein synthesis is mediated by 
GADD34, which is induced via a number of pathways including ATF4 and its target CHOP [1, 
121].  Perhaps for this reason, CHOP deficient cells and animals are resistant to ER stress-
induced cell death [1, 122].  Unsurprisingly, because the PERK-ATF4 axis is triggered by 
cigarette smoke, the induction of CHOP is also observed [47, 48].  Expression of dominant-
negative constructs of PERK or CHOP have been reported to abolish cigarette smoke-induced 
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apoptosis, suggesting that the ISR directly links smoke to cell death [47, 48].  This may involve 
the PERK-ATF4-CHOP-GADD34 axis because loss of GADD34 also renders mice more 
resistant to the pulmonary toxicity of acrolein [104].  However, the inhibition of PERK in order to 
protection airway epithelia from cigarette smoke is brought into question by the observation that 
knockdown of PERK using RNA interference also exaggerates smoke-induced apoptosis in 
normal human bronchial epithelial cells [107].  This likely reflects both the importance of PERK-
mediated attenuation of translation during the response to ER stress and the beneficial effects of 
the ISR during oxidative stress.  However, ameliorating ER stress by overexpression of the 
chaperone BiP or the transcription factor XBP1 can enhance cell viability following exposure to 
smoke [47, 123].  Therefore chemical chaperones might offer similar protection, but this needs 
to be tested formally.  
Hypoxia 
Hypoxia is a common feature of many pulmonary diseases and has relevance to many others, 
notably cancer [124].  A master regulator of the cellular response to hypoxia is Hypoxia-
Inducible Factor (HIF)-1, a basic helix-loop-helix transcription factor consisting of α and β 
subunits [125].  Under normoxic conditions, HIF-1α is hydroxylated in an oxygen-dependent 
manner, promoting its rapid ubiquitination and degradation by the proteasome (reviewed in 
[126]).  During hypoxia, reduced levels of hydroxylation lead to persistence of HIF-1α, 
heterodimerization with HIF-1β, and the induction of genes involved in the hypoxia response.  
Molecular oxygen is also necessary for efficient protein folding within the ER and so, in addition 
to activation of HIF-1-dependent pathways, deficiency of oxygen also serves as a potent trigger 
for the UPR. 
The molecular basis for ER stress during hypoxia - Although a topic of intense investigation, 
the precise mechanisms by which hypoxia induces ER stress remain incompletely understood.  
A variety of processes involved in ER function are either directly or indirectly dependent upon 
molecular oxygen.  The generation of ATP, which is necessary for many processes within the 
ER, consumes oxygen at the mitochondria and during prolonged hypoxia the ratio of ATP:AMP 
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falls in cultured cells [127, 128].  De novo synthesis of secretory proteins at the ER involves 
energy expenditure during gene transcription, mRNA translation, chaperone assisted protein 
folding, protein degradation, intracellular trafficking, and secretion [129-134].  These processes 
can therefore be affected when ATP availability falls owing to reduced mitochondrial respiration. 
The decreased generation of ATP observed in hypoxic conditions can be attributed both to the 
requirement of cytochrome-c oxidase (COX) for oxygen as an electron accepter and the 
inhibition of mitochondrial respiration by pyruvate dehydrogenase kinase (PDK) 1, a 
transcriptional target of HIF-1 [135, 136].  
The most energy expensive component of secretory protein synthesis is mRNA translation itself 
[137].  Limiting GTP has been linked to increased rates of translation errors in reconstituted 
bacterial systems, which could conceivably give rise to missense mutations [138, 139].  Yet it 
would seem unlikely that the ATP depletion seen in prolonged hypoxia would promote sufficient 
levels of translational errors to induce ER stress through protein misfolding.  Indeed, hypoxia 
rapidly reduces the rate of global translation prior to detectable drops in ATP being occurring 
[127].  The entry into the ER of newly synthesised proteins is mediated by the action of ER 
resident chaperones, which also prevent protein aggregation.  BiP is the most abundant 
chaperone within the ER and, as a member of the HSP70 family of proteins, hydrolyses ATP 
during cycles of interactions with its substrates [140].  However, the energetic cost of chaperone 
driven protein folding is relatively small and therefore unlikely to be affected by the levels of ATP 
depletion seen during hypoxia.  In luciferase refolding experiments, a similar HSP70 chaperone 
required only five molecules of ATP to unfold a misfolded protein substrate, which represents an 
energy cost several orders of magnitude lower than that of mRNA translation [141].  Therefore, 
at levels of ATP depletion necessary to impair protein folding, mRNA translation would already 
have dropped dramatically and so no new polypeptide chains would be made.   
Proteins entering the ER often undergo post-translation modifications that guide protein folding 
toward the native state.  Disulphide bond formation is one such modification, the disruption of 
which leads to protein misfolding and ER stress [142].  This process is facilitated by protein 
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disulphide isomerase (PDI), which oxidises a pair of cysteines in a folding protein to generate a 
disulphide bond.  The reduced PDI molecule then shuttles electrons to ERO1, which in turn is 
reoxidised using molecular oxygen [143].  This requirement of ERO1 for molecular oxygen 
suggests that hypoxia might drive ER stress by limiting the formation of disulphide bonds.  
Intriguingly, ERO1 is a prominent target of HIF-1α up-regulation during hypoxia [144].  A number 
of additional ER-disulphide forming pathways have been identified more recently.  Vitamin K 
epoxide reductase (VKOR), Peroxiredoxin 4 (PRDX4), and glutathione peroxidases 7 and 8 
(GPx7/8) have all been shown to form oxidizing equivalents in the ER, and cells lacking ERO1 
display only a slight delay in disulphide formation [145-149].  Whilst VKOR uses oxygen as a 
terminal electron acceptor, PRDX4 and GPx7/8 use hydrogen peroxide instead, although the 
source of ER hydrogen peroxide remains obscure.  While mitochondrial respiration can generate 
hydrogen peroxide, recent findings suggest that the ER membrane is relatively impermeable to 
this, implying the existence of an as yet unknown ER-localised hydrogen peroxide generating 
system [150].  Interestingly, the co-translational formation of disulphide bonds can occur in the 
absence of oxygen, whereas post-translational formation of disulphide bonds and their 
isomerisation is strongly inhibited in anoxic conditions [151].  This suggests that a subset of ER 
client proteins, specifically those requiring the co-translational formation of disulphide bonds, 
may fail to fold in the absence of oxygen, providing a plausible mechanism by which hypoxia 
might induce ER stress.   It is possible that limiting oxygen may have additional effects on the 
post-translational maturation of proteins.  For example, hypoxia has been reported to inhibit N-
linked glycosylation of some proteins [152], although this is not a universal finding and so 
requires further investigation [151].   
It is well known that hypoxia promotes the production of reactive oxygen species (ROS), which 
could conceivably contribute to activation of the UPR [153, 154].  Whilst the ER is undoubtedly 
sensitive to changes in redox, the impact of ROS on ER proteostasis is unclear.  For example, 
although hydrogen peroxide is present within the lumen of the ER, its reaction with proteins is 
energetically unfavourable and so it is unlikely to contribute directly to protein misfolding [155].  
However, cellular hydrogen peroxide can also give rise to lipid peroxides, which have been 
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shown to cause ER stress in cultured cells [156].  This lipid peroxidation is accompanied by 
depletion of reduced glutathione, the most abundant reductive buffering component in the ER, 
and the generation ROS [156].  The extent to which other hypoxia-induced ROS, such as 
superoxide, impact of ER proteostasis is unclear.  It has been proposed that ROS might alter ER 
proteastasis indirectly via an ER resident protein named non-selenocysteine containing 
phospholipid hydroperoxide glutathione peroxidase (NPGPx) [157].  When exposed to ROS, 
NPGPx forms an internal disulphide bond that is subsequently transferred to the ER chaperone 
BiP, leading to its inactivation.  As the master regulator of ER proteostasis, BiP, via NPGPx, may 
provide another link between hypoxia induced ROS and ER stress. 
Pulmonary hypertension - Pulmonary arterial hypertension (PAH) describes an increase in 
blood pressure within pulmonary arteries, characterised by vasoconstriction of the pulmonary 
vasculature and excessive proliferation of smooth muscle cells, ultimately leading to right heart 
failure.  A wide range of drivers of PAH are known, a number of which are associated with tissue 
hypoxia, for example COPD, ILD, and habitation at high altitude [158].  Recently, links have 
been identified between hypoxia induced ER stress and progression of PAH, with evidence 
pointing to effects in a number of tissues including vascular smooth muscle [159], the 
endothelium [160], and hypertrophy in the right ventricle [161].  Notably, expression of the 
protein Nogo-B, a modulator of ER structure, was seen to be up-regulated downstream of ATF6 
in response to hypoxia in smooth muscle cells of pulmonary arteries [162].  This was associated 
with disruption of ER-mitochondrial contacts, reducing phospholipid and calcium transfer 
between the organelles and suppressing mitochondrially driven apoptosis.  Strikingly, Nogo-B 
knockout mice were completely resistant to hypoxia induced PAH.  Moreover, treatment with the 
chemical chaperones 4PBA and tauroursodeoxycholic acid (TUDCA) reversed hypoxia-induced 
PAH in mice, with reduced ATF6 signalling and mitochondrial calcium depletion [159].  Indeed, 
activation of all three arms of the UPR has been observed in the lungs of mice during chronic 
hypoxia induced PAH [161].  The subsequent inflammatory response was attenuated in a 4PBA 
dependent manner.  It is worth noting that the mechanism(s) by which these chemical 
chaperones suppress UPR activation remains under discussion.  4PBA has been suggested to 
 19 
bind hydrophobic regions of unfolded and partially folded proteins, thereby inhibiting aggregation 
[163].  TUDCA is also thought to inhibit mitochondrial dysfunction and apoptosis [164-166].  
However, the precise mechanisms still need to be understood if more effective therapies based 
on them are to be developed. 
Ischaemia - Restriction of blood flow to tissues and organs causing nutrient deprivation and 
hypoxia is described as ischaemia.  Although distinct from the hypoxia of pulmonary failure, the 
models used to study extra-pulmonary ischaemia may shed light on the pathologies of both 
conditions and so will be considered here. It is important to stress, however, that we use these 
observations only to glean clues as to the role of impaired oxygenation on proteostasis in 
peripheral tissue, and they should not be considered models of impaired perfusion of lung 
parenchyma.  PERK is activated in the mouse brain by ischaemia followed by reperfusion, 
leading to phosphorylation of the translation initiation factor eIF2α [167].  Mice lacking the 
transcription factor CHOP, which is up-regulated by eIF2α phosphorylation, were protected 
against ischemia induced neuronal cell death [168].  Whilst transcriptional targets of CHOP are 
cytoprotective in the face of acute ER stress, CHOP drives the resumption of protein synthesis 
and oxidative protein folding, via GADD34 and ERO1 upregulation respectively [1].  As such, the 
PERK arm of the UPR is cytotoxic in the face of chronic ER stress and likely contributes to 
neuronal apoptosis during ischemia.  In addition to hypoxia-induced activation of the UPR, 
reperfusion is associated with the generation of nitric oxide (NO) that is proposed to further 
exacerbate ER stress and CHOP induction [169].  NO is thought to perturb ER calcium 
homeostasis, in part by the inhibition of SERCA, which maintains calcium concentrations in the 
ER, and by promoting glutathionylation of the ryanodine receptor RyR2 leading to calcium efflux 
[170, 171].  The high concentration of calcium in the ER is though to promote the activity of ER 
resident chaperones and folding factors, many of which bind calcium [172].  Recently, depletion 
of ER calcium was shown to inactivate the ER chaperone BiP by inducing its homo-
oligomerisation and thereby preventing interaction with unfolded protein substrates [173].  This 
mode of chaperone inactivation likely contributes to the sensitivity of ER protein folding to 
luminal calcium disturbances, although its prevalence during hypoxia remains to be established.  
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In addition, ER stress induced calcium release promotes cell death by opening of the 
mitochondrial permeability transition pore (MPTP), leading to inner membrane depolarization 
and induction of apoptosis [174].  This process is promoted by the accumulation of calcium 
channels at direct contact sites between the ER and mitochondrial known as mitochondrial 
associated ER-membranes (MAM) [175].  
Ischaemic tissues tend to produce angiogenic factors that promote their reparative 
revascularisation, yet hypoxia-induced ER stress has been suggested to inhibit 
neovascularization though down-regulation of Netrin-1 mediated by the RIDD pathway [176, 
177].  This might suggest that ER stress would have a negative effect of tissue responses to 
ischaemia, but in ischaemic post-conditioning intermittent interruption of blood supply during 
reperfusion has been found to offer some protection to tissues, notably the brain (reviewed in 
[178]).  This is associated with reduced activation of the UPR, with decreased expression of 
CHOP, less apoptosis, and increased expression of the chaperone BiP [179, 180].   
Malignancy - The majority of tumours outgrow their vascular supply and experience at least 
some degree of nutrient deprivation and hypoxia.  As such, ER stress and the UPR are 
important in many aspects of hypoxia driven tumour biology [124].  The rapid reduction of mRNA 
translation during ER stress, facilitated by PERK phosphorylation of eIF2α [181], plays an 
important role in tumour cell survival during the onset of hypoxia.  Disruption of this pathway, 
either by expression of a dominant negative PERK or the non-phosphorylatable S51A mutant of 
eIF2α, impaired cell survival in the face of prolonged hypoxia and gave rise to smaller tumours 
[182].  In addition, ATF4 and CHOP, downstream targets of PERK, are up-regulated in the 
hypoxic core of tumours [182].  PERK offers further protection during hypoxia via the induction of 
cytoprotective autophagy factors such as LC3 and ATG5, which are rapidly turned over during 
hypoxic exposure [183].  Accordingly, pharmacological inhibition of autophagy decreased 
viability of hypoxic tumour cells and sensitized human tumour xenografts to irradiation, providing 
promising avenues for potential therapeutic strategies [183].  Activation of IRE1 by ER stress is 
also important in promoting tumour cell survival in the face of hypoxia, via splicing of an mRNA 
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to encoding the active form of the transcription factor XBP1 [184].  Ablation of this pathway 
dramatically reduced tumour growth, sensitising cells to the hypoxic environment.  Recently, a 
novel role for the IRE1-XBP1 axis during hypoxia was identified in triple negative breast cancer.  
Chen and colleagues showed that transcriptional targets of HIF-1α are also up-regulated by 
XBP1 in a cooperative manner, whereby both factors co-occupy hypoxia responsive target 
genes to promote tumourigenicity [185].  Another example of direct cross talk between the HIF-1 
and ER stress pathways is evident in the amelioration of hypoxic conditions within tumours by 
promoting the pro-angiogenic factor VEGFA.  VEGFA is a direct transcriptional target of both 
HIF-1 [186] and the UPR through the PERK-ATF4 [187, 188] or to a lesser extent IRE1-XBP1 
axes [189].  Direct induction of the UPR appeared to synergise with hypoxia to produce higher 
levels of VEGFA expression than hypoxia alone.  However, this cooperation occurred in an 
ATF4 independent manner, did not increase HIF-1α or HIF-1β expression or nuclear localization, 
but instead appeared to increase HIF-1 transcriptional activity [189].  These data propose 
distinct ATF4 driven and UPR-dependent HIF-1 driven regulation of VEGFA.  The latter may 
provide an example of novel UPR pathways that might be targetable in future therapeutic 
strategies and will no doubt add to the great current interest in pharmacological manipulation of 
ER stress. 
Concluding remarks 
ER stress is therefore both a cause and consequence of pulmonary disease.  The UPR 
signalling pathway is now understood to a remarkable level of precision and potent small 
molecules are currently available to enable its manipulation in vivo.  The observation that some 
features of the UPR, notably the role of IRE1ß, seem to be particular to endoderm-derived 
structures such as the lung raises the possibility that tissue selective therapies may even be 
possible, if the precise function of these pathways can be unpicked.  Despite exciting recent 
advances, much remains to be understood about the full extend of ER stress’ involvement in 
lung disease, making this a thrilling time to be studying proteostasis in pulmonology.    
 22 
Acknowledgement 
JAD, EM and JEC prepared the sections on pulmonary fibrosis, smoke and hypoxia 
respectively.  SJM oversaw writing of the manuscript.  The work was supported by funds from 
the British Lung Foundation, the Alpha1-Foundation, Addenbrooke’s Hospital, Papworth Hospital 




1.  Marciniak, S. J., Yun, C. Y., Oyadomari, S., Novoa, I., Zhang, Y., Jungreis, R., Nagata, K., 
Harding, H. P. & Ron, D. (2004) CHOP induces death by promoting protein synthesis and 
oxidation in the stressed endoplasmic reticulum, Genes Dev. 18, 3066-3077. 
2.  Atkinson, R., Barregård, L., Bellander, T., Burnett, R., Cassee, F., de Oliveira Fernandes, E., 
Forastiere, F., Forsberg, B., Henschel, S., Hoek, G., Holgate, S. T., Janssen, N., Jantunen, M., 
Kelly, F., Lanki, T., Mills, I., Mudway, I., Nieuwenhuijsen, M., Ostro, B., Peters, A., Phillips, D., 
Pope III, C. A., Rapp, R., Sällsten, G., Samoli, E., Straehl, P., van Erp, A., Walton, H. & 
Williams, M. (2013) Review of evidence on health aspects of air pollution – REVIHAAP Project, 
The WHO Regional Office for Europe. 
3.  Marciniak, S. J. (2017) Endoplasmic reticulum stress in lung disease, Eur Respir Rev. 26. 
4.  van 't Wout, E. F., Hiemstra, P. S. & Marciniak, S. J. (2014) The integrated stress response in 
lung disease, Am J Respir Cell Mol Biol. 50, 1005-9. 
5.  Clarke, H. J., Chambers, J. E., Liniker, E. & Marciniak, S. J. (2014) Endoplasmic reticulum 
stress in malignancy, Cancer Cell. 25, 563-73. 
6.  Chambers, J. E. & Marciniak, S. J. (2014) Protein misfolding and ER stress, Am J Physiol 
Cell Physiol. 
7.  Harding, H. P., Zhang, Y. H. & Ron, D. (1999) Protein translation and folding are coupled by 
an endoplasmic-reticulum-resident kinase, Nature. 397, 271-274. 
8.  Marciniak, S. J., Garcia-Bonilla, L., Hu, J., Harding, H. P. & Ron, D. (2006) Activation-
dependent substrate recruitment by the eukaryotic translation initiation factor 2 kinase PERK, J 
Cell Biol. 172, 201-9. 
9.  Hollien, J., Lin, J. H., Li, H., Stevens, N., Walter, P. & Weissman, J. S. (2009) Regulated Ire1-
dependent decay of messenger RNAs in mammalian cells, Journal of Cell Biology. 186, 323-
331. 
10.  Lu, P. D., Jousse, C., Marciniak, S. J., Zhang, Y., Novoa, I., Scheuner, D., Kaufman, R. J., 
Ron, D. & Harding, H. P. (2004) Cytoprotection by pre-emptive conditional phosphorylation of 
translation initiation factor 2, Embo J. 23, 169-179. 
 24 
11.  Calfon, M., Zeng, H. Q., Urano, F., Till, J. H., Hubbard, S. R., Harding, H. P., Clark, S. G. & 
Ron, D. (2002) IRE1 couples endoplasmic reticulum load to secretory capacity by processing 
the XBP-1 mRNA, Nature. 415, 92-96. 
12.  Lee, K., Tirasophon, W., Shen, X., Michalak, M., Prywes, R., Okada, T., Yoshida, H., Mori, 
K. & Kaufman, R. J. (2002) IRE1-mediated unconventional mRNA splicing and S2P-mediated 
ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response, Genes Dev. 
16, 452-466. 
13.  Yoshida, H., Matsui, T., Yamamoto, A., Okada, T. & Mori, K. (2001) XBP1 mRNA is induced 
by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription 
factor, Cell. 107, 881-891. 
14.  Yoshida, H., Okada, T., Haze, K., Yanagi, H., Yura, T., Negishi, M. & Mori, K. (2000) ATF6 
Activated by Proteolysis Binds in the Presence of NF-Y (CBF) Directly to the cis-Acting Element 
Responsible for the Mammalian Unfolded Protein Response, Mol Cell Biol. 20, 6755-6767. 
15.  Ye, J., Rawson, R. B., Komuro, R., Chen, X., Dave, U. P., Prywes, R., Brown, M. S. & 
Goldstein, J. L. (2000) ER Stress Induces Cleavage of Membrane-Bound ATF6 by the Same 
Proteases that Process SREBPs, Mol Cell. 6, 1355-1364. 
16.  Lu, M., Lawrence, D. A., Marsters, S., Acosta-Alvear, D., Kimmig, P., Mendez, A. S., Paton, 
A. W., Paton, J. C., Walter, P. & Ashkenazi, A. (2014) Cell death. Opposing unfolded-protein-
response signals converge on death receptor 5 to control apoptosis, Science. 345, 98-101. 
17.  Mathai, S. K., Yang, I. V., Schwarz, M. I. & Schwartz, D. A. (2015) Incorporating genetics 
into the identification and treatment of Idiopathic Pulmonary Fibrosis, BMC Med. 13, 191. 
18.  Arikan-Ayyildiz, Z., Caglayan-Sozmen, S., Isik, S., Deterding, R., Dishop, M. K., Couderc, 
R., Epaud, R., Louha, M. & Uzuner, N. (2014) Survival of an infant with homozygous surfactant 
protein C (SFTPC) mutation, Pediatr Pulmonol. 49, E112-5. 
19.  Nogee, L. M., Dunbar, A. E., 3rd, Wert, S. E., Askin, F., Hamvas, A. & Whitsett, J. A. (2001) 
A mutation in the surfactant protein C gene associated with familial interstitial lung disease, N 
Engl J Med. 344, 573-9. 
 25 
20.  Thomas, A. Q., Lane, K., Phillips, J., 3rd, Prince, M., Markin, C., Speer, M., Schwartz, D. A., 
Gaddipati, R., Marney, A., Johnson, J., Roberts, R., Haines, J., Stahlman, M. & Loyd, J. E. 
(2002) Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial 
pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred, Am J Respir Crit 
Care Med. 165, 1322-8. 
21.  Johansson, H., Nordling, K., Weaver, T. E. & Johansson, J. (2006) The Brichos domain-
containing C-terminal part of pro-surfactant protein C binds to an unfolded poly-val 
transmembrane segment, J Biol Chem. 281, 21032-9. 
22.  Wang, W. J., Mulugeta, S., Russo, S. J. & Beers, M. F. (2003) Deletion of exon 4 from 
human surfactant protein C results in aggresome formation and generation of a dominant 
negative, J Cell Sci. 116, 683-92. 
23.  Bridges, J. P., Wert, S. E., Nogee, L. M. & Weaver, T. E. (2003) Expression of a human 
surfactant protein C mutation associated with interstitial lung disease disrupts lung development 
in transgenic mice, J Biol Chem. 278, 52739-46. 
24.  Mulugeta, S., Nguyen, V., Russo, S. J., Muniswamy, M. & Beers, M. F. (2005) A surfactant 
protein C precursor protein BRICHOS domain mutation causes endoplasmic reticulum stress, 
proteasome dysfunction, and caspase 3 activation, Am J Respir Cell Mol Biol. 32, 521-30. 
25.  Lawson, W. E., Crossno, P. F., Polosukhin, V. V., Roldan, J., Cheng, D. S., Lane, K. B., 
Blackwell, T. R., Xu, C., Markin, C., Ware, L. B., Miller, G. G., Loyd, J. E. & Blackwell, T. S. 
(2008) Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association 
with altered surfactant protein processing and herpesvirus infection, Am J Physiol Lung Cell Mol 
Physiol. 294, L1119-26. 
26.  Maguire, J. A., Mulugeta, S. & Beers, M. F. (2012) Multiple ways to die: delineation of the 
unfolded protein response and apoptosis induced by Surfactant Protein C BRICHOS mutants, 
Int J Biochem Cell Biol. 44, 101-12. 
27.  Lawson, W. E., Cheng, D. S., Degryse, A. L., Tanjore, H., Polosukhin, V. V., Xu, X. C., 
Newcomb, D. C., Jones, B. R., Roldan, J., Lane, K. B., Morrisey, E. E., Beers, M. F., Yull, F. E. 
 26 
& Blackwell, T. S. (2011) Endoplasmic reticulum stress enhances fibrotic remodeling in the 
lungs, Proc Natl Acad Sci U S A. 108, 10562-7. 
28.  Wright, J. R. (2005) Immunoregulatory functions of surfactant proteins, Nat Rev Immunol. 5, 
58-68. 
29.  Maitra, M., Wang, Y., Gerard, R. D., Mendelson, C. R. & Garcia, C. K. (2010) Surfactant 
protein A2 mutations associated with pulmonary fibrosis lead to protein instability and 
endoplasmic reticulum stress, J Biol Chem. 285, 22103-13. 
30.  Cheong, N., Zhang, H., Madesh, M., Zhao, M., Yu, K., Dodia, C., Fisher, A. B., Savani, R. 
C. & Shuman, H. (2007) ABCA3 is critical for lamellar body biogenesis in vivo, J Biol Chem. 282, 
23811-7. 
31.  Shulenin, S., Nogee, L. M., Annilo, T., Wert, S. E., Whitsett, J. A. & Dean, M. (2004) ABCA3 
gene mutations in newborns with fatal surfactant deficiency, N Engl J Med. 350, 1296-303. 
32.  Doan, M. L., Guillerman, R. P., Dishop, M. K., Nogee, L. M., Langston, C., Mallory, G. B., 
Sockrider, M. M. & Fan, L. L. (2008) Clinical, radiological and pathological features of ABCA3 
mutations in children, Thorax. 63, 366-73. 
33.  Weichert, N., Kaltenborn, E., Hector, A., Woischnik, M., Schams, A., Holzinger, A., Kern, S. 
& Griese, M. (2011) Some ABCA3 mutations elevate ER stress and initiate apoptosis of lung 
epithelial cells, Respiratory research. 12, 4. 
34.  Gerondopoulos, A., Langemeyer, L., Liang, J. R., Linford, A. & Barr, F. A. (2012) BLOC-3 
mutated in Hermansky-Pudlak syndrome is a Rab32/38 guanine nucleotide exchange factor, 
Curr Biol. 22, 2135-9. 
35.  Mahavadi, P., Korfei, M., Henneke, I., Liebisch, G., Schmitz, G., Gochuico, B. R., Markart, 
P., Bellusci, S., Seeger, W., Ruppert, C. & Guenther, A. (2010) Epithelial stress and apoptosis 
underlie Hermansky-Pudlak syndrome-associated interstitial pneumonia, Am J Respir Crit Care 
Med. 182, 207-19. 
36.  Steele, M. P., Speer, M. C., Loyd, J. E., Brown, K. K., Herron, A., Slifer, S. H., Burch, L. H., 
Wahidi, M. M., Phillips, J. A., 3rd, Sporn, T. A., McAdams, H. P., Schwarz, M. I. & Schwartz, D. 
 27 
A. (2005) Clinical and pathologic features of familial interstitial pneumonia, Am J Respir Crit 
Care Med. 172, 1146-52. 
37.  Korfei, M., Ruppert, C., Mahavadi, P., Henneke, I., Markart, P., Koch, M., Lang, G., Fink, L., 
Bohle, R. M., Seeger, W., Weaver, T. E. & Guenther, A. (2008) Epithelial endoplasmic reticulum 
stress and apoptosis in sporadic idiopathic pulmonary fibrosis, Am J Respir Crit Care Med. 178, 
838-46. 
38.  Cha, S. I., Ryerson, C. J., Lee, J. S., Kukreja, J., Barry, S. S., Jones, K. D., Elicker, B. M., 
Kim, D. S., Papa, F. R., Collard, H. R. & Wolters, P. J. (2012) Cleaved cytokeratin-18 is a 
mechanistically informative biomarker in idiopathic pulmonary fibrosis, Respiratory research. 13, 
105. 
39.  Korfei, M., von der Beck, D., Henneke, I., Markart, P., Ruppert, C., Mahavadi, P., Ghanim, 
B., Klepetko, W., Fink, L., Meiners, S., Kramer, O. H., Seeger, W., Vancheri, C. & Guenther, A. 
(2013) Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary 
fibrosis (IPF), non-specific interstitial pneumonia (NSIP) and organ donors, J Proteomics. 85, 
109-28. 
40.  Moore, B. B. & Moore, T. A. (2015) Viruses in Idiopathic Pulmonary Fibrosis. Etiology and 
Exacerbation, Ann Am Thorac Soc. 12 Suppl 2, S186-92. 
41.  Tang, Y. W., Johnson, J. E., Browning, P. J., Cruz-Gervis, R. A., Davis, A., Graham, B. S., 
Brigham, K. L., Oates, J. A., Jr., Loyd, J. E. & Stecenko, A. A. (2003) Herpesvirus DNA is 
consistently detected in lungs of patients with idiopathic pulmonary fibrosis, J Clin Microbiol. 41, 
2633-40. 
42.  Isler, J. A., Skalet, A. H. & Alwine, J. C. (2005) Human cytomegalovirus infection activates 
and regulates the unfolded protein response, J Virol. 79, 6890-9. 
43.  Baumgartner, K. B., Samet, J. M., Stidley, C. A., Colby, T. V. & Waldron, J. A. (1997) 
Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis, Am J Respir Crit Care Med. 
155, 242-8. 
 28 
44.  Jorgensen, E., Stinson, A., Shan, L., Yang, J., Gietl, D. & Albino, A. P. (2008) Cigarette 
smoke induces endoplasmic reticulum stress and the unfolded protein response in normal and 
malignant human lung cells, BMC Cancer. 8, 229. 
45.  Hengstermann, A. & Muller, T. (2008) Endoplasmic reticulum stress induced by aqueous 
extracts of cigarette smoke in 3T3 cells activates the unfolded-protein-response-dependent 
PERK pathway of cell survival, Free Radic Biol Med. 44, 1097-107. 
46.  Kenche, H., Ye, Z. W., Vedagiri, K., Richards, D. M., Gao, X. H., Tew, K. D., Townsend, D. 
M. & Blumental-Perry, A. (2016) Adverse Outcomes Associated with Cigarette Smoke Radicals 
Related to Damage to Protein-disulfide Isomerase, J Biol Chem. 291, 4763-78. 
47.  Tagawa, Y., Hiramatsu, N., Kasai, A., Hayakawa, K., Okamura, M., Yao, J. & Kitamura, M. 
(2008) Induction of apoptosis by cigarette smoke via ROS-dependent endoplasmic reticulum 
stress and CCAAT/enhancer-binding protein-homologous protein (CHOP), Free Radic Biol Med. 
45, 50-9. 
48.  Tagawa, Y., Hiramatsu, N., Kato, H., Sakoh, T., Nakajima, S., Hayakawa, K., Saito, Y., 
Johno, H., Takahashi, S., Gu, L., Yao, J. & Kitamura, M. (2011) Induction of CCAAT/enhancer-
binding protein-homologous protein by cigarette smoke through the superoxide anion-triggered 
PERK-eIF2alpha pathway, Toxicology. 287, 105-12. 
49.  Geraghty, P., Baumlin, N., Salathe, M. A., Foronjy, R. F. & D'Armiento, J. M. (2016) 
Glutathione Peroxidase-1 Suppresses the Unfolded Protein Response upon Cigarette Smoke 
Exposure, Mediators Inflamm. 2016, 9461289. 
50.  Zarcone, M. C., Duistermaat, E., van Schadewijk, A., Jedynska, A., Hiemstra, P. S. & 
Kooter, I. M. (2016) Cellular response of mucociliary differentiated primary bronchial epithelial 
cells to diesel exhaust, Am J Physiol Lung Cell Mol Physiol. 311, L111-23. 
51.  Zarcone, M. C., van Schadewijk, A., Duistermaat, E., Hiemstra, P. S. & Kooter, I. M. (2017) 
Diesel exhaust alters the response of cultured primary bronchial epithelial cells from patients 
with chronic obstructive pulmonary disease (COPD) to non-typeable Haemophilus influenzae, 
Respiratory research. 18, 27. 
 29 
52.  Watterson, T. L., Hamilton, B., Martin, R. & Coulombe, R. A., Jr. (2009) Urban particulate 
matter causes ER stress and the unfolded protein response in human lung cells, Toxicol Sci. 
112, 111-22. 
53.  Laing, S., Wang, G., Briazova, T., Zhang, C., Wang, A., Zheng, Z., Gow, A., Chen, A. F., 
Rajagopalan, S., Chen, L. C., Sun, Q. & Zhang, K. (2010) Airborne particulate matter selectively 
activates endoplasmic reticulum stress response in the lung and liver tissues, Am J Physiol Cell 
Physiol. 299, C736-49. 
54.  Winterbottom, C. J., Shah, R. J., Patterson, K. C., Kreider, M. E., Panettieri, R. A., Jr., 
Rivera-Lebron, B., Miller, W. T., Litzky, L. A., Penning, T. M., Heinlen, K., Jackson, T., Localio, 
A. R. & Christie, J. D. (2017) Exposure to Ambient Particulate Matter is Associated With 
Accelerated Functional Decline in Idiopathic Pulmonary Fibrosis, Chest. doi: 
10.1016/j.chest.2017.07.034. 
55.  Kamp, D. W., Liu, G., Cheresh, P., Kim, S. J., Mueller, A., Lam, A. P., Trejo, H., Williams, 
D., Tulasiram, S., Baker, M., Ridge, K., Chandel, N. S. & Beri, R. (2013) Asbestos-induced 
alveolar epithelial cell apoptosis. The role of endoplasmic reticulum stress response, Am J 
Respir Cell Mol Biol. 49, 892-901. 
56.  Ryan, A. J., Larson-Casey, J. L., He, C., Murthy, S. & Carter, A. B. (2014) Asbestos-induced 
disruption of calcium homeostasis induces endoplasmic reticulum stress in macrophages, J Biol 
Chem. 289, 33391-403. 
57.  Schwaiblmair, M., Berghaus, T., Haeckel, T., Wagner, T. & von Scheidt, W. (2010) 
Amiodarone-induced pulmonary toxicity: an under-recognized and severe adverse effect?, Clin 
Res Cardiol. 99, 693-700. 
58.  Mahavadi, P., Henneke, I., Ruppert, C., Knudsen, L., Venkatesan, S., Liebisch, G., 
Chambers, R. C., Ochs, M., Schmitz, G., Vancheri, C., Seeger, W., Korfei, M. & Guenther, A. 
(2014) Altered surfactant homeostasis and alveolar epithelial cell stress in amiodarone-induced 
lung fibrosis, Toxicol Sci. 142, 285-97. 
59.  Tanaka, Y., Ishitsuka, Y., Hayasaka, M., Yamada, Y., Miyata, K., Endo, M., Kondo, Y., 
Moriuchi, H., Irikura, M., Tanaka, K., Mizushima, T., Oike, Y. & Irie, T. (2015) The exacerbating 
 30 
roles of CCAAT/enhancer-binding protein homologous protein (CHOP) in the development of 
bleomycin-induced pulmonary fibrosis and the preventive effects of tauroursodeoxycholic acid 
(TUDCA) against pulmonary fibrosis in mice, Pharmacol Res. 99, 52-62. 
60.  Zhao, H., Qin, H. Y., Cao, L. F., Chen, Y. H., Tan, Z. X., Zhang, C. & Xu, D. X. (2015) 
Phenylbutyric acid inhibits epithelial-mesenchymal transition during bleomycin-induced lung 
fibrosis, Toxicol Lett. 232, 213-20. 
61.  Ordonez, A., Snapp, E. L., Tan, L., Miranda, E., Marciniak, S. J. & Lomas, D. A. (2013) 
Endoplasmic reticulum polymers impair luminal protein mobility and sensitize to cellular stress in 
alpha1-antitrypsin deficiency, Hepatology. 57, 2049-60. 
62.  Bridges, J. P., Xu, Y., Na, C. L., Wong, H. R. & Weaver, T. E. (2006) Adaptation and 
increased susceptibility to infection associated with constitutive expression of misfolded SP-C, J 
Cell Biol. 172, 395-407. 
63.  Raghu, G., Weycker, D., Edelsberg, J., Bradford, W. Z. & Oster, G. (2006) Incidence and 
prevalence of idiopathic pulmonary fibrosis, Am J Respir Crit Care Med. 174, 810-6. 
64.  Tsakiri, K. D., Cronkhite, J. T., Kuan, P. J., Xing, C., Raghu, G., Weissler, J. C., Rosenblatt, 
R. L., Shay, J. W. & Garcia, C. K. (2007) Adult-onset pulmonary fibrosis caused by mutations in 
telomerase, Proc Natl Acad Sci U S A. 104, 7552-7. 
65.  Brown, M. K. & Naidoo, N. (2012) The endoplasmic reticulum stress response in aging and 
age-related diseases, Frontiers in physiology. 3, 263. 
66.  Torres-Gonzalez, E., Bueno, M., Tanaka, A., Krug, L. T., Cheng, D. S., Polosukhin, V. V., 
Sorescu, D., Lawson, W. E., Blackwell, T. S., Rojas, M. & Mora, A. L. (2012) Role of 
endoplasmic reticulum stress in age-related susceptibility to lung fibrosis, Am J Respir Cell Mol 
Biol. 46, 748-56. 
67.  Bueno, M., Lai, Y. C., Romero, Y., Brands, J., St Croix, C. M., Kamga, C., Corey, C., 
Herazo-Maya, J. D., Sembrat, J., Lee, J. S., Duncan, S. R., Rojas, M., Shiva, S., Chu, C. T. & 
Mora, A. L. (2015) PINK1 deficiency impairs mitochondrial homeostasis and promotes lung 
fibrosis, J Clin Invest. 125, 521-38. 
 31 
68.  Maguire, J. A., Mulugeta, S. & Beers, M. F. (2011) Endoplasmic reticulum stress induced by 
surfactant protein C BRICHOS mutants promotes proinflammatory signaling by epithelial cells, 
Am J Respir Cell Mol Biol. 44, 404-14. 
69.  Zhang, K. & Kaufman, R. J. (2008) From endoplasmic-reticulum stress to the inflammatory 
response, Nature. 454, 455-62. 
70.  Keane, M. P., Arenberg, D. A., Lynch, J. P., 3rd, Whyte, R. I., Iannettoni, M. D., Burdick, M. 
D., Wilke, C. A., Morris, S. B., Glass, M. C., DiGiovine, B., Kunkel, S. L. & Strieter, R. M. (1997) 
The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary 
fibrosis, J Immunol. 159, 1437-43. 
71.  Guiot, J., Henket, M., Corhay, J. L., Moermans, C. & Louis, R. (2017) Sputum biomarkers in 
IPF: Evidence for raised gene expression and protein level of IGFBP-2, IL-8 and MMP-7, PLoS 
One. 12, e0171344. 
72.  Car, B. D., Meloni, F., Luisetti, M., Semenzato, G., Gialdroni-Grassi, G. & Walz, A. (1994) 
Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic 
pulmonary fibrosis and pulmonary sarcoidosis, Am J Respir Crit Care Med. 149, 655-9. 
73.  Wynn, T. A. (2011) Integrating mechanisms of pulmonary fibrosis, J Exp Med. 208, 1339-
50. 
74.  Willis, B. C., Liebler, J. M., Luby-Phelps, K., Nicholson, A. G., Crandall, E. D., du Bois, R. M. 
& Borok, Z. (2005) Induction of epithelial-mesenchymal transition in alveolar epithelial cells by 
transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis, Am J Pathol. 
166, 1321-32. 
75.  Kim, K. K., Kugler, M. C., Wolters, P. J., Robillard, L., Galvez, M. G., Brumwell, A. N., 
Sheppard, D. & Chapman, H. A. (2006) Alveolar epithelial cell mesenchymal transition develops 
in vivo during pulmonary fibrosis and is regulated by the extracellular matrix in Proc Natl Acad 
Sci U S A  pp. 13180-5, United States. 
76.  Tanjore, H., Xu, X. C., Polosukhin, V. V., Degryse, A. L., Li, B., Han, W., Sherrill, T. P., 
Plieth, D., Neilson, E. G., Blackwell, T. S. & Lawson, W. E. (2009) Contribution of epithelial-
derived fibroblasts to bleomycin-induced lung fibrosis, Am J Respir Crit Care Med. 180, 657-65. 
 32 
77.  Tanjore, H., Cheng, D. S., Degryse, A. L., Zoz, D. F., Abdolrasulnia, R., Lawson, W. E. & 
Blackwell, T. S. (2011) Alveolar epithelial cells undergo epithelial-to-mesenchymal transition in 
response to endoplasmic reticulum stress, J Biol Chem. 286, 30972-80. 
78.  Zhong, Q., Zhou, B., Ann, D. K., Minoo, P., Liu, Y., Banfalvi, A., Krishnaveni, M. S., 
Dubourd, M., Demaio, L., Willis, B. C., Kim, K. J., duBois, R. M., Crandall, E. D., Beers, M. F. & 
Borok, Z. (2011) Role of endoplasmic reticulum stress in epithelial-mesenchymal transition of 
alveolar epithelial cells: effects of misfolded surfactant protein, Am J Respir Cell Mol Biol. 45, 
498-509. 
79.  Baek, H. A., Kim, D. S., Park, H. S., Jang, K. Y., Kang, M. J., Lee, D. G., Moon, W. S., 
Chae, H. J. & Chung, M. J. (2012) Involvement of endoplasmic reticulum stress in 
myofibroblastic differentiation of lung fibroblasts, Am J Respir Cell Mol Biol. 46, 731-9. 
80.  Mo, X. T., Zhou, W. C., Cui, W. H., Li, D. L., Li, L. C., Xu, L., Zhao, P. & Gao, J. (2015) 
Inositol-requiring protein 1 - X-box-binding protein 1 pathway promotes epithelial-mesenchymal 
transition via mediating snail expression in pulmonary fibrosis, Int J Biochem Cell Biol. 65, 230-
8. 
81.  Yao, Y., Wang, Y., Zhang, Z., He, L., Zhu, J., Zhang, M., He, X., Cheng, Z., Ao, Q., Cao, Y., 
Yang, P., Su, Y., Zhao, J., Zhang, S., Yu, Q., Ning, Q., Xiang, X., Xiong, W., Wang, C. Y. & Xu, 
Y. (2016) Chop Deficiency Protects Mice Against Bleomycin-induced Pulmonary Fibrosis by 
Attenuating M2 Macrophage Production, Mol Ther. 24, 915-25. 
82.  Thannickal, V. J., Toews, G. B., White, E. S., Lynch, J. P., 3rd & Martinez, F. J. (2004) 
Mechanisms of pulmonary fibrosis, Annu Rev Med. 55, 395-417. 
83.  Mulugeta, S., Maguire, J. A., Newitt, J. L., Russo, S. J., Kotorashvili, A. & Beers, M. F. 
(2007) Misfolded BRICHOS SP-C mutant proteins induce apoptosis via caspase-4- and 
cytochrome c-related mechanisms, Am J Physiol Lung Cell Mol Physiol. 293, L720-9. 
84.  Kelsen, S. G., Duan, X., Ji, R., Perez, O., Liu, C. & Merali, S. (2008) Cigarette smoke 
induces an unfolded protein response in the human lung: a proteomic approach, Am J Respir 
Cell Mol Biol. 38, 541-50. 
 33 
85.  Kenche, H., Baty, C. J., Vedagiri, K., Shapiro, S. D. & Blumental-Perry, A. (2013) Cigarette 
smoking affects oxidative protein folding in endoplasmic reticulum by modifying protein disulfide 
isomerase, FASEB J. 27, 965-77. 
86.  Moon, H. G., Zheng, Y., An, C. H., Kim, Y. K. & Jin, Y. (2013) CCN1 secretion induced by 
cigarette smoking extracts augments IL-8 release from bronchial epithelial cells, PLoS One. 8, 
e68199. 
87.  Bertolotti, A., Wang, X., Novoa, I., Jungreis, R., Schlessinger, K., Cho, J. H., West, A. B. & 
Ron, D. (2001) Increased sensitivity to dextran sodium sulfate colitis in IRE1b deficient mice, J 
Clin Invest. 107, 585-593. 
88.  Imagawa, Y., Hosoda, A., Sasaka, S., Tsuru, A. & Kohno, K. (2008) RNase domains 
determine the functional difference between IRE1alpha and IRE1beta, FEBS Lett. 582, 656-60. 
89.  Iqbal, J., Dai, K., Seimon, T., Jungreis, R., Oyadomari, M., Kuriakose, G., Ron, D., Tabas, I. 
& Hussain, M. M. (2008) IRE1beta inhibits chylomicron production by selectively degrading MTP 
mRNA, Cell Metab. 7, 445-55. 
90.  Tsuru, A., Fujimoto, N., Takahashi, S., Saito, M., Nakamura, D., Iwano, M., Iwawaki, T., 
Kadokura, H., Ron, D. & Kohno, K. (2013) Negative feedback by IRE1beta optimizes mucin 
production in goblet cells, Proc Natl Acad Sci U S A. 110, 2864-9. 
91.  Min, T., Bodas, M., Mazur, S. & Vij, N. (2011) Critical role of proteostasis-imbalance in 
pathogenesis of COPD and severe emphysema, J Mol Med (Berl). 89, 577-93. 
92.  Gan, G., Hu, R., Dai, A., Tan, S., Ouyang, Q., Fu, D. & Jiang, D. (2011) The role of 
endoplasmic reticulum stress in emphysema results from cigarette smoke exposure, Cell Physiol 
Biochem. 28, 725-32. 
93.  Geraghty, P., Wallace, A. & D'Armiento, J. M. (2011) Induction of the unfolded protein 
response by cigarette smoke is primarily an activating transcription factor 4-C/EBP homologous 
protein mediated process, Int J Chron Obstruct Pulmon Dis. 6, 309-19. 
94.  Yamada, Y., Tomaru, U., Ishizu, A., Ito, T., Kiuchi, T., Ono, A., Miyajima, S., Nagai, K., 
Higashi, T., Matsuno, Y., Dosaka-Akita, H., Nishimura, M., Miwa, S. & Kasahara, M. (2015) 
 34 
Decreased proteasomal function accelerates cigarette smoke-induced pulmonary emphysema in 
mice, Lab Invest. 95, 625-34. 
95.  Yun, J. H., Morrow, J., Owen, C. A., Qiu, W., Glass, K., Lao, T., Jiang, Z., Perrella, M. A., 
Silverman, E. K., Zhou, X. & Hersh, C. P. (2017) Transcriptomic Analysis of Lung Tissue from 
Cigarette Smoke-Induced Emphysema Murine Models and Human Chronic Obstructive 
Pulmonary Disease Show Shared and Distinct Pathways, Am J Respir Cell Mol Biol. 57, 47-58. 
96.  Guerassimov, A., Hoshino, Y., Takubo, Y., Turcotte, A., Yamamoto, M., Ghezzo, H., 
Triantafillopoulos, A., Whittaker, K., Hoidal, J. R. & Cosio, M. G. (2004) The development of 
emphysema in cigarette smoke-exposed mice is strain dependent, Am J Respir Crit Care Med. 
170, 974-80. 
97.  Vecchio, D., Arezzini, B., Pecorelli, A., Valacchi, G., Martorana, P. A. & Gardi, C. (2010) 
Reactivity of mouse alveolar macrophages to cigarette smoke is strain dependent, Am J Physiol 
Lung Cell Mol Physiol. 298, L704-13. 
98.  Gordon, T. & Bosland, M. (2009) Strain-dependent differences in susceptibility to lung 
cancer in inbred mice exposed to mainstream cigarette smoke, Cancer Lett. 275, 213-20. 
99.  Radder, J. E., Gregory, A. D., Leme, A. S., Cho, M. H., Chu, Y., Kelly, N. J., Bakke, P., 
Gulsvik, A., Litonjua, A. A., Sparrow, D., Beaty, T. H., Crapo, J. D., Silverman, E. K., Zhang, Y., 
Berndt, A. & Shapiro, S. D. (2017) Variable Susceptibility to Cigarette Smoke-Induced 
Emphysema in 34 Inbred Strains of Mice Implicates Abi3bp in Emphysema Susceptibility, Am J 
Respir Cell Mol Biol. 57, 367-375. 
100.  Chen, Z., Wang, D., Liu, X., Pei, W., Li, J., Cao, Y., Zhang, J., An, Y., Nie, J. & Tong, J. 
(2015) Oxidative DNA damage is involved in cigarette smoke-induced lung injury in rats, Environ 
Health Prev Med. 20, 318-24. 
101.  Taylor, M., Vella, L. & Carr, T. (2014) Assessment of an in vitro model of lung epithelial cell 
stress responses, Free Radic Biol Med. 75 Suppl 1, S51. 
102.  van Rijt, S. H., Keller, I. E., John, G., Kohse, K., Yildirim, A. O., Eickelberg, O. & Meiners, 
S. (2012) Acute cigarette smoke exposure impairs proteasome function in the lung, Am J 
Physiol Lung Cell Mol Physiol. 303, L814-23. 
 35 
103.  Fassio, A. & Sitia, R. (2002) Formation, isomerisation and reduction of disulphide bonds 
during protein quality control in the endoplasmic reticulum, Histochem Cell Biol. 117, 151-7. 
104.  Sun, Y., Ito, S., Nishio, N., Tanaka, Y., Chen, N., Liu, L. & Isobe, K. (2015) Enhancement 
of the acrolein-induced production of reactive oxygen species and lung injury by GADD34, Oxid 
Med Cell Longev. 2015, 170309. 
105.  Crespillo-Casado, A., Chambers, J. E., Fischer, P. M., Marciniak, S. J. & Ron, D. (2017) 
PPP1R15A-mediated dephosphorylation of eIF2alpha is unaffected by Sephin1 or Guanabenz, 
eLife. 6, e26109. doi: 10.7554/eLife.26109. 
106.  Das, I., Krzyzosiak, A., Schneider, K., Wrabetz, L., D'Antonio, M., Barry, N., Sigurdardottir, 
A. & Bertolotti, A. (2015) Preventing proteostasis diseases by selective inhibition of a 
phosphatase regulatory subunit, Science. 348, 239-42. 
107.  Yuan, T., Luo, B. L., Wei, T. H., Zhang, L., He, B. M. & Niu, R. C. (2012) Salubrinal 
protects against cigarette smoke extract-induced HBEpC apoptosis likely via regulating the 
activity of PERK-eIF2alpha signaling pathway, Arch Med Res. 43, 522-9. 
108.  Stevenson, C. S., Docx, C., Webster, R., Battram, C., Hynx, D., Giddings, J., Cooper, P. 
R., Chakravarty, P., Rahman, I., Marwick, J. A., Kirkham, P. A., Charman, C., Richardson, D. L., 
Nirmala, N. R., Whittaker, P. & Butler, K. (2007) Comprehensive gene expression profiling of rat 
lung reveals distinct acute and chronic responses to cigarette smoke inhalation, Am J Physiol 
Lung Cell Mol Physiol. 293, L1183-93. 
109.  Rangasamy, T., Cho, C. Y., Thimmulappa, R. K., Zhen, L., Srisuma, S. S., Kensler, T. W., 
Yamamoto, M., Petrache, I., Tuder, R. M. & Biswal, S. (2004) Genetic ablation of Nrf2 enhances 
susceptibility to cigarette smoke-induced emphysema in mice, J Clin Invest. 114, 1248-59. 
110.  Adair-Kirk, T. L., Atkinson, J. J., Griffin, G. L., Watson, M. A., Kelley, D. G., DeMello, D., 
Senior, R. M. & Betsuyaku, T. (2008) Distal airways in mice exposed to cigarette smoke: Nrf2-
regulated genes are increased in Clara cells, Am J Respir Cell Mol Biol. 39, 400-11. 
111.  Harding, H. P., Zhang, Y. H., Zeng, H. Q., Novoa, I., Lu, P. D., Calfon, M., Sadri, N., Yun, 
C., Popko, B., Paules, R., Stojdl, D. F., Bell, J. C., Hettmann, T., Leiden, J. M. & Ron, D. (2003) 
 36 
An integrated stress response regulates amino acid metabolism and resistance to oxidative 
stress, Molecular Cell. 11, 619-633. 
112.  Ye, P., Mimura, J., Okada, T., Sato, H., Liu, T., Maruyama, A., Ohyama, C. & Itoh, K. 
(2014) Nrf2- and ATF4-dependent upregulation of xCT modulates the sensitivity of T24 bladder 
carcinoma cells to proteasome inhibition, Mol Cell Biol. 34, 3421-34. 
113.  He, C. H., Gong, P., Hu, B., Stewart, D., Choi, M. E., Choi, A. M. & Alam, J. (2001) 
Identification of activating transcription factor 4 (ATF4) as a Nrf2 interacting protein: Implication 
for heme oxygenase-1 gene regulation, J Biol Chem. 26, 26. 
114.  DeNicola, G. M., Chen, P. H., Mullarky, E., Sudderth, J. A., Hu, Z., Wu, D., Tang, H., Xie, 
Y., Asara, J. M., Huffman, K. E., Wistuba, II, Minna, J. D., DeBerardinis, R. J. & Cantley, L. C. 
(2015) NRF2 regulates serine biosynthesis in non-small cell lung cancer, Nat Genet. 47, 1475-
81. 
115.  Steiling, K., van den Berge, M., Hijazi, K., Florido, R., Campbell, J., Liu, G., Xiao, J., 
Zhang, X., Duclos, G., Drizik, E., Si, H., Perdomo, C., Dumont, C., Coxson, H. O., Alekseyev, Y. 
O., Sin, D., Pare, P., Hogg, J. C., McWilliams, A., Hiemstra, P. S., Sterk, P. J., Timens, W., 
Chang, J. T., Sebastiani, P., O'Connor, G. T., Bild, A. H., Postma, D. S., Lam, S., Spira, A. & 
Lenburg, M. E. (2013) A dynamic bronchial airway gene expression signature of chronic 
obstructive pulmonary disease and lung function impairment, Am J Respir Crit Care Med. 187, 
933-42. 
116.  Cullinan, S. B., Zhang, D., Hannink, M., Arvisais, E., Kaufman, R. J. & Diehl, J. A. (2003) 
Nrf2 Is a Direct PERK Substrate and Effector of PERK-Dependent Cell Survival, Mol Cell Biol. 
23, 7198-7209. 
117.  Cullinan, S. B. & Diehl, J. A. (2004) PERK-dependent activation of Nrf2 contributes to 
redox homeostasis and cell survival following endoplasmic reticulum stress, J Biol Chem. 279, 
20108-17. 
118.  Lu, P. D., Jousse, C., Marciniak, S. J., Zhang, Y., Novoa, I., Scheuner, D., Kaufman, R. J., 
Ron, D. & Harding, H. P. (2004) Cytoprotection by pre-emptive conditional phosphorylation of 
translation initiation factor 2, The EMBO journal. 23, 169-79. 
 37 
119.  Churg, A., Cosio, M. & Wright, J. L. (2008) Mechanisms of cigarette smoke-induced 
COPD: insights from animal models, Am J Physiol Lung Cell Mol Physiol. 294, L612-31. 
120.  Tabas, I. & Ron, D. (2011) Integrating the mechanisms of apoptosis induced by 
endoplasmic reticulum stress, Nature cell biology. 13, 184-90. 
121.  Ma, Y. & Hendershot, L. M. (2003) Delineation of a Negative Feedback Regulatory Loop 
That Controls Protein Translation during Endoplasmic Reticulum Stress, J Biol Chem. 278, 
34864-73. 
122.  Zinszner, H., Kuroda, M., Wang, X., Batchvarova, N., Lightfoot, R. T., Remotti, H., 
Stevens, J. L. & Ron, D. (1998) CHOP is implicated in programmed cell death in response to 
impaired function of the endoplasmic reticulum, Genes Dev. 12, 982-995. 
123.  Huang, C., Wang, J. J., Ma, J. H., Jin, C., Yu, Q. & Zhang, S. X. (2015) Activation of the 
UPR protects against cigarette smoke-induced RPE apoptosis through up-regulation of Nrf2, J 
Biol Chem. 290, 5367-80. 
124.  Obacz, J., Avril, T., Rubio-Patino, C., Bossowski, J. P., Igbaria, A., Ricci, J. E. & Chevet, E. 
(2017) Regulation of tumor-stroma interactions by the unfolded protein response, Febs J. 
125.  Wang, G. L., Jiang, B. H., Rue, E. A. & Semenza, G. L. (1995) Hypoxia-inducible factor 1 
is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension, Proc Natl Acad Sci 
U S A. 92, 5510-4. 
126.  Schofield, C. J. & Ratcliffe, P. J. (2004) Oxygen sensing by HIF hydroxylases, Nat Rev Mol 
Cell Biol. 5, 343-54. 
127.  Liu, L., Cash, T. P., Jones, R. G., Keith, B., Thompson, C. B. & Simon, M. C. (2006) 
Hypoxia-induced energy stress regulates mRNA translation and cell growth, Mol Cell. 21, 521-
31. 
128.  Emerling, B. M., Weinberg, F., Snyder, C., Burgess, Z., Mutlu, G. M., Viollet, B., Budinger, 
G. R. & Chandel, N. S. (2009) Hypoxic activation of AMPK is dependent on mitochondrial ROS 
but independent of an increase in AMP/ATP ratio, Free Radic Biol Med. 46, 1386-91. 
129.  Lynch, M. & Marinov, G. K. (2015) The bioenergetic costs of a gene, Proc Natl Acad Sci U 
S A. 112, 15690-5. 
 38 
130.  Aoyagi, Y., Tasaki, I., Okumura, J. & Muramatsu, T. (1988) Energy cost of whole-body 
protein synthesis measured in vivo in chicks, Comp Biochem Physiol A Comp Physiol. 91, 765-
8. 
131.  Clare, D. K. & Saibil, H. R. (2013) ATP-driven molecular chaperone machines, 
Biopolymers. 99, 846-59. 
132.  Princiotta, M. F., Finzi, D., Qian, S. B., Gibbs, J., Schuchmann, S., Buttgereit, F., Bennink, 
J. R. & Yewdell, J. W. (2003) Quantitating protein synthesis, degradation, and endogenous 
antigen processing, Immunity. 18, 343-54. 
133.  Balch, W. E., Elliott, M. M. & Keller, D. S. (1986) ATP-coupled transport of vesicular 
stomatitis virus G protein between the endoplasmic reticulum and the Golgi, J Biol Chem. 261, 
14681-9. 
134.  Rothman, J. E. (1994) Mechanisms of intracellular protein transport, Nature. 372, 55-63. 
135.  Chandel, N., Budinger, G. R., Kemp, R. A. & Schumacker, P. T. (1995) Inhibition of 
cytochrome-c oxidase activity during prolonged hypoxia, The American journal of physiology. 
268, L918-25. 
136.  Kim, J. W., Tchernyshyov, I., Semenza, G. L. & Dang, C. V. (2006) HIF-1-mediated 
expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular 
adaptation to hypoxia, Cell Metab. 3, 177-85. 
137.  Buttgereit, F. & Brand, M. D. (1995) A hierarchy of ATP-consuming processes in 
mammalian cells, Biochem J. 312 ( Pt 1), 163-7. 
138.  Thompson, R. C. & Stone, P. J. (1977) Proofreading of the codon-anticodon interaction on 
ribosomes, Proc Natl Acad Sci U S A. 74, 198-202. 
139.  Thompson, R. C., Dix, D. B., Gerson, R. B. & Karim, A. M. (1981) A GTPase reaction 
accompanying the rejection of Leu-tRNA2 by UUU-programmed ribosomes. Proofreading of the 
codon-anticodon interaction by ribosomes, J Biol Chem. 256, 81-6. 
140.  Mayer, M. P. (2013) Hsp70 chaperone dynamics and molecular mechanism, Trends in 
biochemical sciences. 38, 507-14. 
 39 
141.  Sharma, S. K., De los Rios, P., Christen, P., Lustig, A. & Goloubinoff, P. (2010) The kinetic 
parameters and energy cost of the Hsp70 chaperone as a polypeptide unfoldase, Nat Chem 
Biol. 6, 914-20. 
142.  Laitusis, A. L., Brostrom, M. A. & Brostrom, C. O. (1999) The dynamic role of GRP78/BiP 
in the coordination of mRNA translation with protein processing, J Biol Chem. 274, 486-93. 
143.  Gross, E., Sevier, C. S., Heldman, N., Vitu, E., Bentzur, M., Kaiser, C. A., Thorpe, C. & 
Fass, D. (2006) Generating disulfides enzymatically: reaction products and electron acceptors of 
the endoplasmic reticulum thiol oxidase Ero1p, Proc Natl Acad Sci U S A. 103, 299-304. 
144.  May, D., Itin, A., Gal, O., Kalinski, H., Feinstein, E. & Keshet, E. (2005) Ero1-L alpha plays 
a key role in a HIF-1-mediated pathway to improve disulfide bond formation and VEGF secretion 
under hypoxia: implication for cancer, Oncogene. 24, 1011-20. 
145.  Zito, E., Melo, E. P., Yang, Y., Wahlander, A., Neubert, T. A. & Ron, D. (2010) Oxidative 
protein folding by an endoplasmic reticulum-localized peroxiredoxin, Mol Cell. 40, 787-97. 
146.  Tavender, T. J., Springate, J. J. & Bulleid, N. J. (2010) Recycling of peroxiredoxin IV 
provides a novel pathway for disulphide formation in the endoplasmic reticulum, EMBO J. 29, 
4185-97. 
147.  Rutkevich, L. A. & Williams, D. B. (2012) Vitamin K epoxide reductase contributes to 
protein disulfide formation and redox homeostasis within the endoplasmic reticulum, Mol Biol 
Cell. 23, 2017-27. 
148.  Wang, L., Zhang, L., Niu, Y., Sitia, R. & Wang, C. C. (2014) Glutathione peroxidase 7 
utilizes hydrogen peroxide generated by Ero1alpha to promote oxidative protein folding, Antioxid 
Redox Signal. 20, 545-56. 
149.  Ramming, T., Hansen, H. G., Nagata, K., Ellgaard, L. & Appenzeller-Herzog, C. (2014) 
GPx8 peroxidase prevents leakage of H2O2 from the endoplasmic reticulum, Free Radic Biol 
Med. 70, 106-16. 
150.  Konno, T., Pinho Melo, E., Lopes, C., Mehmeti, I., Lenzen, S., Ron, D. & Avezov, E. (2015) 
ERO1-independent production of H2O2 within the endoplasmic reticulum fuels Prdx4-mediated 
oxidative protein folding, J Cell Biol. 211, 253-9. 
 40 
151.  Koritzinsky, M., Levitin, F., van den Beucken, T., Rumantir, R. A., Harding, N. J., Chu, K. 
C., Boutros, P. C., Braakman, I. & Wouters, B. G. (2013) Two phases of disulfide bond formation 
have differing requirements for oxygen, J Cell Biol. 203, 615-27. 
152.  Ren, Y., Hao, P., Law, S. K. & Sze, S. K. (2014) Hypoxia-induced changes to integrin 
alpha 3 glycosylation facilitate invasion in epidermoid carcinoma cell line A431, Mol Cell 
Proteomics. 13, 3126-37. 
153.  Guzy, R. D., Hoyos, B., Robin, E., Chen, H., Liu, L., Mansfield, K. D., Simon, M. C., 
Hammerling, U. & Schumacker, P. T. (2005) Mitochondrial complex III is required for hypoxia-
induced ROS production and cellular oxygen sensing, Cell Metab. 1, 401-8. 
154.  Brunelle, J. K., Bell, E. L., Quesada, N. M., Vercauteren, K., Tiranti, V., Zeviani, M., 
Scarpulla, R. C. & Chandel, N. S. (2005) Oxygen sensing requires mitochondrial ROS but not 
oxidative phosphorylation, Cell metabolism. 1, 409-14. 
155.  Winterbourn, C. C. (2013) The biological chemistry of hydrogen peroxide, Methods 
Enzymol. 528, 3-25. 
156.  Vladykovskaya, E., Sithu, S. D., Haberzettl, P., Wickramasinghe, N. S., Merchant, M. L., 
Hill, B. G., McCracken, J., Agarwal, A., Dougherty, S., Gordon, S. A., Schuschke, D. A., Barski, 
O. A., O'Toole, T., D'Souza, S. E., Bhatnagar, A. & Srivastava, S. (2012) Lipid peroxidation 
product 4-hydroxy-trans-2-nonenal causes endothelial activation by inducing endoplasmic 
reticulum stress, J Biol Chem. 287, 11398-409. 
157.  Wei, P. C., Hsieh, Y. H., Su, M. I., Jiang, X., Hsu, P. H., Lo, W. T., Weng, J. Y., Jeng, Y. 
M., Wang, J. M., Chen, P. L., Chang, Y. C., Lee, K. F., Tsai, M. D., Shew, J. Y. & Lee, W. H. 
(2012) Loss of the oxidative stress sensor NPGPx compromises GRP78 chaperone activity and 
induces systemic disease, Mol Cell. 48, 747-59. 
158.  Simonneau, G., Galie, N., Rubin, L. J., Langleben, D., Seeger, W., Domenighetti, G., 
Gibbs, S., Lebrec, D., Speich, R., Beghetti, M., Rich, S. & Fishman, A. (2004) Clinical 
classification of pulmonary hypertension, J Am Coll Cardiol. 43, 5S-12S. 
 41 
159.  Dromparis, P., Paulin, R., Stenson, T. H., Haromy, A., Sutendra, G. & Michelakis, E. D. 
(2013) Attenuating endoplasmic reticulum stress as a novel therapeutic strategy in pulmonary 
hypertension, Circulation. 127, 115-25. 
160.  Lenna, S., Han, R. & Trojanowska, M. (2014) Endoplasmic reticulum stress and 
endothelial dysfunction, IUBMB Life. 66, 530-7. 
161.  Koyama, M., Furuhashi, M., Ishimura, S., Mita, T., Fuseya, T., Okazaki, Y., Yoshida, H., 
Tsuchihashi, K. & Miura, T. (2014) Reduction of endoplasmic reticulum stress by 4-phenylbutyric 
acid prevents the development of hypoxia-induced pulmonary arterial hypertension, Am J 
Physiol Heart Circ Physiol. 306, H1314-23. 
162.  Sutendra, G., Dromparis, P., Wright, P., Bonnet, S., Haromy, A., Hao, Z., McMurtry, M. S., 
Michalak, M., Vance, J. E., Sessa, W. C. & Michelakis, E. D. (2011) The role of Nogo and the 
mitochondria-endoplasmic reticulum unit in pulmonary hypertension, Sci Transl Med. 3, 88ra55. 
163.  Cortez, L. & Sim, V. (2014) The therapeutic potential of chemical chaperones in protein 
folding diseases, Prion. 8. 
164.  Rodrigues, C. M., Fan, G., Ma, X., Kren, B. T. & Steer, C. J. (1998) A novel role for 
ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane 
perturbation, J Clin Invest. 101, 2790-9. 
165.  Rodrigues, C. M., Sola, S., Sharpe, J. C., Moura, J. J. & Steer, C. J. (2003) 
Tauroursodeoxycholic acid prevents Bax-induced membrane perturbation and cytochrome C 
release in isolated mitochondria, Biochemistry. 42, 3070-80. 
166.  Azzaroli, F., Mehal, W., Soroka, C. J., Wang, L., Lee, J., Crispe, I. N. & Boyer, J. L. (2002) 
Ursodeoxycholic acid diminishes Fas-ligand-induced apoptosis in mouse hepatocytes, 
Hepatology. 36, 49-54. 
167.  Kumar, R., Azam, S., Sullivan, J. M., Owen, C., Cavener, D. R., Zhang, P., Ron, D., 
Harding, H. P., Chen, J. J., Han, A., White, B. C., Krause, G. S. & DeGracia, D. J. (2001) Brain 
ischemia and reperfusion activates the eukaryotic initiation factor 2alpha kinase, PERK, J 
Neurochem. 77, 1418-21. 
 42 
168.  Tajiri, S., Oyadomari, S., Yano, S., Morioka, M., Gotoh, T., Hamada, J. I., Ushio, Y. & Mori, 
M. (2004) Ischemia-induced neuronal cell death is mediated by the endoplasmic reticulum stress 
pathway involving CHOP, Cell Death Differ. 11, 403-15. 
169.  Kawahara, K., Oyadomari, S., Gotoh, T., Kohsaka, S., Nakayama, H. & Mori, M. (2001) 
Induction of CHOP and apoptosis by nitric oxide in p53-deficient microglial cells, FEBS Lett. 506, 
135-9. 
170.  Doutheil, J., Althausen, S., Treiman, M. & Paschen, W. (2000) Effect of nitric oxide on 
endoplasmic reticulum calcium homeostasis, protein synthesis and energy metabolism, Cell 
Calcium. 27, 107-15. 
171.  Bull, R., Finkelstein, J. P., Galvez, J., Sanchez, G., Donoso, P., Behrens, M. I. & Hidalgo, 
C. (2008) Ischemia enhances activation by Ca2+ and redox modification of ryanodine receptor 
channels from rat brain cortex, J Neurosci. 28, 9463-72. 
172.  Milner, R. E., Famulski, K. S. & Michalak, M. (1992) Calcium binding proteins in the 
sarcoplasmic/endoplasmic reticulum of muscle and nonmuscle cells, Mol Cell Biochem. 112, 1-
13. 
173.  Preissler, S., Chambers, J. E., Crespillo-Casado, A., Avezov, E., Miranda, E., Perez, J., 
Hendershot, L. M., Harding, H. P. & Ron, D. (2015) Physiological modulation of BiP activity by 
trans-protomer engagement of the interdomain linker, eLife. 4, e08961. 
174.  Deniaud, A., Sharaf el dein, O., Maillier, E., Poncet, D., Kroemer, G., Lemaire, C. & 
Brenner, C. (2008) Endoplasmic reticulum stress induces calcium-dependent permeability 
transition, mitochondrial outer membrane permeabilization and apoptosis, Oncogene. 27, 285-
99. 
175.  Szabadkai, G., Bianchi, K., Varnai, P., De Stefani, D., Wieckowski, M. R., Cavagna, D., 
Nagy, A. I., Balla, T. & Rizzuto, R. (2006) Chaperone-mediated coupling of endoplasmic 
reticulum and mitochondrial Ca2+ channels, J Cell Biol. 175, 901-11. 
176.  Binet, F., Mawambo, G., Sitaras, N., Tetreault, N., Lapalme, E., Favret, S., Cerani, A., 
Leboeuf, D., Tremblay, S., Rezende, F., Juan, A. M., Stahl, A., Joyal, J. S., Milot, E., Kaufman, 
R. J., Guimond, M., Kennedy, T. E. & Sapieha, P. (2013) Neuronal ER stress impedes myeloid-
 43 
cell-induced vascular regeneration through IRE1alpha degradation of netrin-1, Cell metabolism. 
17, 353-71. 
177.  Hollien, J. & Weissman, J. S. (2006) Decay of endoplasmic reticulum-localized mRNAs 
during the unfolded protein response, Science. 313, 104-7. 
178.  Fan, Y. Y., Hu, W. W., Nan, F. & Chen, Z. (2017) Postconditioning-induced 
neuroprotection, mechanisms and applications in cerebral ischemia, Neurochem Int. 107, 43-56. 
179.  Liu, X., Zhao, S., Liu, F., Kang, J., Xiao, A., Li, F., Zhang, C., Yan, F., Zhao, H., Luo, M., 
Luo, Y. & Ji, X. (2014) Remote ischemic postconditioning alleviates cerebral ischemic injury by 
attenuating endoplasmic reticulum stress-mediated apoptosis, Transl Stroke Res. 5, 692-700. 
180.  Yuan, Y., Guo, Q., Ye, Z., Pingping, X., Wang, N. & Song, Z. (2011) Ischemic 
postconditioning protects brain from ischemia/reperfusion injury by attenuating endoplasmic 
reticulum stress-induced apoptosis through PI3K-Akt pathway, Brain Res. 1367, 85-93. 
181.  Harding, H., Zhang, Y., Bertolotti, A., Zeng, H. & Ron, D. (2000) Perk is essential for 
translational regulation and cell survival during the unfolded protein response, Mol Cell. 5, 897-
904. 
182.  Bi, M., Naczki, C., Koritzinsky, M., Fels, D., Blais, J., Hu, N., Harding, H., Novoa, I., Varia, 
M., Raleigh, J., Scheuner, D., Kaufman, R. J., Bell, J., Ron, D., Wouters, B. G. & Koumenis, C. 
(2005) ER stress-regulated translation increases tolerance to extreme hypoxia and promotes 
tumor growth, EMBO J. 24, 3470-81. 
183.  Rouschop, K. M., van den Beucken, T., Dubois, L., Niessen, H., Bussink, J., Savelkouls, 
K., Keulers, T., Mujcic, H., Landuyt, W., Voncken, J. W., Lambin, P., van der Kogel, A. J., 
Koritzinsky, M. & Wouters, B. G. (2010) The unfolded protein response protects human tumor 
cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5, J Clin 
Invest. 120, 127-41. 
184.  Romero-Ramirez, L., Cao, H., Nelson, D., Hammond, E., Lee, A. H., Yoshida, H., Mori, K., 
Glimcher, L. H., Denko, N. C., Giaccia, A. J., Le, Q. T. & Koong, A. C. (2004) XBP1 is essential 
for survival under hypoxic conditions and is required for tumor growth, Cancer Res. 64, 5943-7. 
 44 
185.  Chen, X., Iliopoulos, D., Zhang, Q., Tang, Q., Greenblatt, M. B., Hatziapostolou, M., Lim, 
E., Tam, W. L., Ni, M., Chen, Y., Mai, J., Shen, H., Hu, D. Z., Adoro, S., Hu, B., Song, M., Tan, 
C., Landis, M. D., Ferrari, M., Shin, S. J., Brown, M., Chang, J. C., Liu, X. S. & Glimcher, L. H. 
(2014) XBP1 promotes triple-negative breast cancer by controlling the HIF1alpha pathway, 
Nature. 508, 103-107. 
186.  Forsythe, J. A., Jiang, B. H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D. & Semenza, 
G. L. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-
inducible factor 1, Mol Cell Biol. 16, 4604-13. 
187.  Ghosh, R., Lipson, K. L., Sargent, K. E., Mercurio, A. M., Hunt, J. S., Ron, D. & Urano, F. 
(2010) Transcriptional regulation of VEGF-A by the unfolded protein response pathway, PLoS 
One. 5, e9575. 
188.  Pereira, E. R., Liao, N., Neale, G. A. & Hendershot, L. M. (2010) Transcriptional and post-
transcriptional regulation of proangiogenic factors by the unfolded protein response, PLoS ONE. 
5. 
189.  Pereira, E. R., Frudd, K., Awad, W. & Hendershot, L. M. (2014) Endoplasmic reticulum 
(ER) stress and hypoxia response pathways interact to potentiate hypoxia-inducible factor 1 
(HIF-1) transcriptional activity on targets like vascular endothelial growth factor (VEGF), J Biol 
Chem. 289, 3352-64. 
190.  Willander, H., Askarieh, G., Landreh, M., Westermark, P., Nordling, K., Keranen, H., 
Hermansson, E., Hamvas, A., Nogee, L. M., Bergman, T., Saenz, A., Casals, C., Aqvistg, J., 
Jornvall, H., Berglund, H., Presto, J., Knight, S. D. & Johansson, J. (2012) High-resolution 
structure of a BRICHOS domain and its implications for anti-amyloid chaperone activity on lung 
surfactant protein C, Proc Natl Acad Sci U S A. 109, 2325-9. 
191.  Johansson, J., Szyperski, T., Curstedt, T. & Wuthrich, K. (1994) The NMR structure of the 
pulmonary surfactant-associated polypeptide SP-C in an apolar solvent contains a valyl-rich 




Figure 1.  The Unfolded Protein Response 
Nascent proteins enter the ER and co-translationally associate with ER chaperones, e.g. BiP, 
and other components of the folding machinery.  If they reached their correct fold, they are 
released from the ER to proceed along the secretory pathway via the Golgi. Accumulation of 
unfolded proteins in the ER triggers the unfolded protein response (UPR):  IRE1 initiates 
unconventional splicing of mRNA encoding the transcription factor XBP1; ATF6 activation 
involves its trafficking to the Golgi apparatus where it is cleaved to release a transcription factor 
domain.  Both XBP1 and cleaved ATF6 up-regulate components of the ER folding and 
degradation machineries.  PERK phosphorylates eIF2α to inhibit translation of most proteins, 
while promoting the translation of ATF4.  IRE1 can also reduce translation during stress, by 
degrading ER-localized mRNA transcripts in a process termed regulated IRE1-dependent decay 
(RIDD). 
 
Figure 2. Structure of surfactant protein C.   
(A) The crystal structure of the surfactant protein C (SFTPC) BRICHOS domain [DOI: 
10.2210/pdb2yad/pdb] [190] and the NMR structure of the valine-rich α-helix of SFTPC in an 
apolar solvent [DOI: 10.2210/pdb1spf/pdb] [191] were used to generate a model of the SFTPC 
pro-protein.  The linker region, predicted to be an unstructured polypeptide chain, is represented 
as a line.  (B) Enlargement of the crystal structure of the BRICHOS domain of SFTPC. ER stress 
can be induced by mutations affecting (i) the conserved disulphide bond between cysteines 121 
and 189 highlighted in blue; (ii) Leucine 188 highlighted in red; (iii) the region encoded by exon-4 
highlighted in orange, which disrupts a disulphide bond between cysteines 120 and 148.   
Figures were generated using PyMOL v1.7.4.4, Schrödinger LLC. 
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